| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate 50micrograms aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Flunisolide 25 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide 55microgram aqueous nasal spray (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Tramazoline hydrochloride+dexamethasone isonicotinate (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide 1 mg/g oromucosal paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alclometasone dipropionate 0.05% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alclometasone dipropionate 500 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclometasone dipropionate 250 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone valerate 0.12% foam (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone 0.1% scalp application (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone 0.1% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone 0.1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone 0.1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone+salicylic acid 0.05/3% scalp application |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone 0.05% cream (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 nanogram/1 milligram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone+neomycin sulfate 0.1/0.5% ointment (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desoxymethasone 0.05% oily cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluocortolone 0.5% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluocortolone 0.5% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fludroxycortide 125 microgram/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone+clotrimazole 0.05/1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin- and dexamethasone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ciprofloxacin 0.3% + dexamethasone 0.1% sterile otic suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasol propionate 500 microgram/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone- and clotrimazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing betamethasone and fusidic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Betamethasone+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing betamethasone and salicylic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasol propionate+neomycin sulfate+Nystatin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lidocaine and methylprednisolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methylprednisolone- and neomycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing neomycin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone+econazole (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasol propionate 500 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexamethasone 0.1% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dexamethasone 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.001% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.003% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.01% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.01% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.03% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.03% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.1% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.3% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 0.3% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely prednisolone acetate 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clobetasol propionate 0.05% scalp application |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical betamethasone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical beclomethasone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone 20mg rectal foam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclometasone-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing betamethasone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Parenteral betamethasone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral dexamethasone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexamethasone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical compound dexamethasone preparation (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing methylprednisolone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Parenteral methylprednisolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing prednisolone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednisolone drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing prednisolone in rectal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral triamcinolone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Parenteral triamcinolone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Topical triamcinolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely prednisolone sodium phosphate 5 milligram/1 milliliter conventional release solution for ear or eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing prednicarbate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Prednicarbate 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Clocortolone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing clocortolone pivalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely clocortolone pivalate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluprednidene-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fluprednidene- and miconazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely fluprednidene acetate 1 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Amcinonide 1 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Loteprednol etabonate + tobramycin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Halobetasol propionate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glucocorticoid hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]